NeoGenomics’ Charts Miss the Mark – Predictability Remains Elusive

Sparse signals and flat price patterns provide limited foresight for the coming year

NEO NeoGenomics, Inc.

In this report

01

Price Signals vs Fundamentals

Momentum, volatility, relative strength → revenue, margin, ROE

→

02

Institutional Flow Impact

Ownership changes vs price returns — leading or lagging?

→

03

Earnings Surprise Patterns

Beat rates, pre-drift, announcement reactions, post-drift

→

04

Multi-Signal Integration

Signal coverage and data quality assessment

→

05

Signal Discovery Summary

Top signals, cross-company patterns, monitoring recommendations

→

Price Signals vs Fundamental Outcomes

NeoGenomics, Inc. (NEO) — Signal-Fundamental Correlation

How to read this section: We test whether three price-based signals — 12-month momentum (trailing stock return), realized volatility (annualized standard deviation of daily returns), and relative strength (stock return minus S&P 500 return) — predict next-quarter fundamental outcomes: revenue growth, operating margin change, and ROE change (all year-over-year to remove seasonality). Each cell shows the Pearson correlation (r) between signal at quarter Q and outcome at quarter Q+1. Values closer to +1 or −1 indicate stronger predictive relationships. “n” is the number of quarterly observations.

The analysis of NeoGenomics, Inc. (NEO) over a 45‑quarter window (2015Q1‑2026Q1) reveals that none of the examined price‑based signals—12‑month momentum, realized volatility, or relative strength—demonstrate strong predictive power for core fundamentals such as revenue growth, margin change, or ROE change. The strongest observed relationships are modest: 12‑month momentum correlates with revenue growth (r=0.317, p=0.044, n=41) and ROE change (r=0.298, p=0.059, n=41), while realized volatility shows a weak positive link to margin change (r=0.339, p=0.030, n=41). Relative strength exhibits the highest correlation with revenue growth (r=0.397, p=0.010, n=41), yet this still falls below the threshold for notable predictive strength (|r|≥0.4). Across the sample, no consistent cross‑company patterns emerge, underscoring that price signals for NeoGenomics do not reliably forecast fundamental outcomes within the examined horizon.

12‑month momentum correlates with revenue growth at r=0.317 (p=0.044, n=41), indicating a weak predictive link.
Realized volatility relates to margin change at r=0.339 (p=0.030, n=41), the only statistically significant volatility‑fundamental relationship.
Relative strength exhibits the highest correlation with revenue growth (r=0.397, p=0.010, n=41) but remains below the notable threshold of |r|≥0.4 for strong predictive power.

Limitations: The sample size is limited to 45 quarters, reducing statistical robustness and increasing susceptibility to outlier effects. Correlations do not imply causation; observed relationships may be driven by external macro‑economic regimes or sector‑wide dynamics rather than intrinsic company factors. Signal effectiveness appears regime‑dependent, and the analysis does not account for structural breaks (e.g., acquisitions, regulatory changes) that could alter price‑fundamental linkages.

NEO

For NeoGenomics, 12‑month momentum offers a weak but statistically significant association with revenue growth (r=0.317, p=0.044) and borderline significance for ROE change (r=0.298, p=0.059). This suggests that upward price trends may partially capture market expectations of top‑line expansion, though the effect size is limited. Realized volatility is weakly linked to margin improvement (r=0.339, p=0.030), implying that periods of higher price fluctuation could coincide with operational adjustments affecting profitability, but causality remains uncertain. Relative strength shows the most pronounced correlation with revenue growth (r=0.397, p=0.010), indicating that stocks outperforming peers may be reflecting anticipated sales acceleration. However, all correlations fall short of the strong threshold (|r|≥0.6) and should be interpreted cautiously.

Price Signals vs Fundamental Outcomes

NeoGenomics, Inc. (NEO) — Correlation Heatmap

Institutional Flow vs Price Impact

NeoGenomics, Inc. (NEO) — Institutional Flow Analysis

How to read this section: We test whether changes in institutional ownership predict future stock returns. Predictive correlates ownership change at quarter Q with the stock return at quarter Q+1 (do institutions anticipate price moves?). Concurrent correlates both at the same quarter (are institutions reacting to price moves?). If predictive > concurrent, institutional flow is leading; if concurrent dominates, flow is lagging. Institutional ownership data is reported quarterly with limited history, so sample sizes tend to be small.

The analysis of institutional flow versus price movement for NeoGenomics, Inc. (NEO) reveals an ambiguous relationship. Both predictive and concurrent correlation metrics hover around |r|=0.35, indicating weak statistical associations that do not meet the threshold for strong or even notable signal strength (|r|≥0.4). Consequently, there is no clear evidence that institutional investors either lead price changes with superior information or simply follow market momentum. Given the modest sample size of 39‑40 quarterly observations, the statistical significance (p≈0.03) suggests the correlations are unlikely to be pure chance, yet their magnitude remains insufficient for actionable insight. The lack of a discernible lead‑lag pattern implies that institutional activity in NEO may reflect broader market dynamics rather than firm‑specific informational advantage.

Institutional Flow Metrics

Predictive correlation is weak and negative (r = -0.3511), failing to indicate institutional leadership.
Concurrent correlation is also weak but positive (r = 0.345), hinting at possible momentum following.
Both correlations are statistically significant at the 5% level but lack practical strength (|r|<0.4).
No clear lead‑lag pattern emerges, limiting confidence in institutional flow as a forecasting tool for NEO.

Limitations: Quarterly institutional flow data provides limited temporal granularity, obscuring short‑term dynamics. Sample size is modest (≈40 observations), increasing uncertainty around correlation estimates. Correlation does not imply causation; observed relationships may be driven by external market factors rather than direct institutional influence.

NEO

For NeoGenomics, the predictive correlation between quarterly institutional flow and subsequent price change is r = -0.3511 (p = 0.0284, n = 39), indicating a weak inverse relationship where higher inflows are modestly associated with later price declines. The concurrent correlation is r = 0.345 (p = 0.0292, n = 40), reflecting a weak positive link between flow and same‑period price movement, suggestive of momentum following. Because both metrics fall below the notable threshold (|r|≥0.4) and display opposite signs, they do not support a consistent narrative that institutions either possess an informational edge or merely chase price trends in NEO.

Earnings Surprise Patterns

NeoGenomics, Inc. (NEO) — Earnings Surprise Profile

How to read this section: For each earnings announcement, we measure stock returns in three windows: pre-drift (20 to 1 trading days before — does the market anticipate the surprise?), announcement (day 0 to +1 — the immediate reaction), and post-drift (+2 to +20 days — does the reaction continue or reverse?). Events are classified as positive (>2% EPS surprise), negative (<−2%), or inline. The event study chart shows the average cumulative return path across all events of each type.

NeoGenomics, Inc. (NEO) has delivered earnings surprises in roughly seven out of ten reporting periods, posting a beat rate of 69.4% across 36 events. The average EPS surprise of 23.46% and revenue surprise of 11.64% indicate that when the company exceeds expectations, it does so by a material margin, while misses are relatively modest. However, the pattern lacks sequential consistency—there are no streaks of consecutive beats or misses—which suggests that each quarter’s outcome is driven more by discrete operational factors than by a persistent earnings momentum.

Returns by Surprise Direction

NEO beats expectations in ~70% of quarters, with large average EPS (23.5%) and revenue (11.6%) surprises.
Pre‑announcement drift is positive for beats (+5.1%) but weakly correlated with surprise direction (r = -0.0337), indicating little predictive leakage.
Announcement reactions add ~4.8% on beats and -5.3% on misses, while post‑announcement drifts are modest, suggesting most information is priced in quickly.
The widening surprise trend points to growing divergence between consensus forecasts and actual results.

NEO

The pre‑announcement drift for positive surprise events averages +5.13%, implying investors tend to price in some upside ahead of the release, but the magnitude is modest and statistically insignificant given the small sample (n=25). The announcement reaction is a further 4.75% gain on average, reinforcing that the market digests the surprise incrementally rather than all at once. Post‑announcement drift turns slightly positive (+1.51%) for beats, indicating limited continuation after the news is fully incorporated. For negative surprises, pre‑drift is marginally negative (-1.24%), the announcement reaction is sharply down (-5.32%), and post‑drift reverts modestly upward (+0.73%). The near‑zero correlation between pre‑drift returns and surprise magnitude (r = -0.0337) suggests no reliable information leakage; price movements before earnings are not predictive of the direction or size of the eventual surprise. The widening surprise trend signals that the gap between consensus expectations and actual outcomes is expanding, which could reflect increasing analyst uncertainty or volatility in the company’s operating environment.

Earnings Surprise Patterns

NeoGenomics, Inc. (NEO) — Event Study

Multi-Signal Integration

NeoGenomics, Inc. (NEO) — Signal Coverage

The signal integration review for NeoGenomics, Inc. (NEO) reveals a sparse predictive landscape. While the data infrastructure is rated strong, the breadth of available signals is limited, resulting in low overall coverage. Consequently, the few observable patterns—such as an earnings beat rate of 69%—do not coalesce into a consistent predictive framework, and no price-fundamental or institutional models exhibit notable power.

NeoGenomics exhibits low predictive signal density, limiting reliable forecasting.
High data quality does not translate into strong or notable signals due to limited coverage.
The absence of convergent price-fundamental and institutional cues suggests divergent patterns in the available metrics.

NEO

For NeoGenomics, the inventory shows zero price-fundamental signals with notable or strong predictive strength, and neither institutional nor pre‑drift predictive signals are present. Earnings consistency is mixed, and signal coverage is low despite high data quality. The modest beat rate of 69% suggests occasional positive surprises but does not align with other leading indicators, indicating divergent rather than convergent signal behavior. Overall predictability is limited; the company appears less patterned in its financial outcomes over the near term.

Signal Discovery Summary

NeoGenomics, Inc. (NEO) — Summary & Recommendations

The signal discovery exercise applied lagged Pearson correlations to quarterly fundamentals, institutional flow metrics, and earnings-event windows for NeoGenomics, Inc. (NEO). Across the permissible sample sizes—minimum eight quarters for price-fundamental links, five periods for flow data, and four earnings events—no correlation reached the predefined thresholds of |r| ≥ 0.4, indicating an absence of statistically notable predictive relationships for this business. Consequently, the analysis could not identify any reliable leading indicators that consistently precede price movements or returns for NEO. The broader cross-company scan also failed to surface any recurring patterns, underscoring the limited predictability of the dataset within the examined horizon.

Predictability Rankings

NEO low

No statistically notable predictive signals were identified for NeoGenomics.

Monitoring Recommendations

Track quarterly earnings releases and compare actual results to consensus estimates, as event-driven volatility remains the primary driver of short-term price moves.
Observe changes in institutional ownership filings, recognizing that any emerging flow patterns are currently unsupported by statistical evidence.
Monitor broader industry trends in molecular diagnostics and oncology testing, which may influence NeoGenomics' fundamentals outside the scope of historical correlations.

Key Takeaways

1. The analysis found no predictive signals for NeoGenomics meeting the strong (|r| ≥ 0.6) or notable (|r| ≥ 0.4) criteria.
2. Sample constraints—minimum eight quarterly observations and limited earnings events—restrict statistical power, especially for newer biotech firms.
3. Absence of cross-company patterns suggests that any potential signals are likely company‑specific rather than sector‑wide within the current data window.

The study relies on bivariate Pearson correlations with lagged variables and modest sample sizes, which limits detection power and may produce spurious findings. Correlation does not imply causation, and relationships observed in past regimes may not persist under changing market conditions or company fundamentals. Multivariate interactions were not examined, so complex predictive dynamics could remain undiscovered.

NEO

Related Reports

Explore more at Finexus Reports

Report written 2026-06-07 • Finexus

Disclaimer

This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.

The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.

Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.